Don’t Panic: The FDA’s Guide To Saving Drug Approvals From Suspect Data

Drug approvals can survive manufacturing data integrity failures, US FDA official says. Here’s how.

Don't panic
fda: don't panic, make a plan. A global plan. • Source: Wikimedia Commons

It can end badly when the US Food and Drug Administration learns it has approved drugs based on suspect manufacturing data – but it doesn’t have to if companies keep their cool and take certain key steps that an agency official recently described.

The official, Derek Smith, outlined the process for remedying such situations when he spoke at the recent Drug Information Association...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Manufacturing

More from Compliance